Clinical Services > Cardiology

Flinders University joins male health research alliance

23 June, 2021

Flinders University has become a research partner of the Freemasons Centre for Male Health & Wellbeing, broadening the scope and footprint of the centre's activities.

1.8m Australians missing out on recommended heart treatment

06 May, 2021

Treating high-risk patients with recommended blood pressure and cholesterol-lowering medicines could prevent more than 103,000 heart attacks, strokes and heart-related deaths.

REDFEB highlights how to recognise and handle a heart attack

21 January, 2021

Heart Research Australia is encouraging Australians to wear red and donate during February, to raise awareness for heart disease and funds for life-saving research.

Gout treatment halts coronary disease progression

09 September, 2020

A trial has found that heart attacks and the need for coronary stenting or bypass surgery reduced by 30% in patients taking low-dose colchicine, a drug commonly used to treat gout.

WA team treat heart disease with cancer therapy

07 August, 2020

The team of doctors used stereotactic ablative body radiotherapy to treat a patient with a life-threatening arrhythmia known as ventricular tachycardia.

Access opens for minimally invasive heart treatment

02 July, 2020

Australians living with symptoms of severe aortic stenosis will now have access to a minimally invasive heart treatment that was previously reserved for only the sickest patients.

Digital solution holds hope for atrial fibrillation outcomes

24 June, 2020

A research project underway in western Sydney could see marked improvements for patients with atrial fibrillation.

Cancer patients miss out on vital heart care

24 June, 2020

A University of Newcastle study has revealed that heart patients with a history of cancer are less likely to receive the heart medications they need.

Transplant success with heart-in-a-box method

18 June, 2020

A new heart transplant method means that a donated heart can now be transported and preserved for longer than previously possible.

Clot buster holds hope for treating COVID-19

10 June, 2020

An Australian-developed anti-clotting drug could treat one of the most devastating, life-threatening complications of COVID-19 — microscopic blood clots.

Concern for Australians missing vital GP visits

22 May, 2020

Tens of thousands of Australians with chronic diseases are putting themselves at risk by missing vital visits to their GP.

Monash device may reduce risk of artery-widening procedure

31 January, 2020

Researchers from Monash University are developing a device to safely and effectively treat the most common cardiovascular disease: atherosclerosis, or narrowing of the arteries.

Heart Foundation highlights smoke haze health risks

09 January, 2020

The Heart Foundation is urging those with conditions such as heart failure, and those aged 65 years and over, to be aware of the risks to their health and the need to protect themselves.

Cardiologists express concern over study complication data

20 December, 2019 by David O’Donnell* and Daniel Cehic**

Unlike the Ganesan study, published in Internal Medicine Journal, GenesisCare cardiologists have found marked variation in complication rates for cardiac device implantation.

Public vs private: similar safety outcomes for heart procedures

18 December, 2019

Public and private hospitals have similar safety outcomes for pacemaker and defibrillator implant surgeries, according to a comparative study.

  • All content Copyright © 2021 Westwick-Farrow Pty Ltd